SGX Market Updates By SGX My Gateway

SGX Market Information

SGX My Gateway Market Updates

2018 September Quarter S-REITs Earnings Schedule

18 October 2018

The latest quarterly reporting season for Singapore REITs and Business Trusts began last week, with SPH REIT releasing its results for the year ended 31 Aug 2018. This was followed by Keppel REIT, Keppel DC REIT, and First REIT, which unveiled their 3Q earnings earlier this week. The iEdge S-REIT Index has 36 constituents, comprising 28 REITs, six stapled trusts and two property trusts. With a combined market capitalisation of nearly S$80 billion, they have averaged a total return of -5.7% in the 2018 YTD, bringing their 12-month and three-year total returns to -2.5% and 24.5% respectively.

2018 September Quarter STI Earnings Schedule

SGX My Gateway

17 October 2018

Yesterday, Singapore Press Holdings kick-started the September quarter earnings reporting season for the constituents of the benchmark STI by releasing its results for the year ended 31 Aug 2018. In the YTD, the STI has generated a total return of -7%. The 30 Index constituents have a combined market capitalisation of over S$500 billion. They have averaged a total return of -9.6% in the YTD, bringing their 12-month and three-year total returns to -8.8% and +12.9% respectively.

Three Largest Agriculture Stocks Averaged 8% Total Return in 3Q18

SGX My Gateway

11 October 2018

SGX lists six stocks with a market capitalisation above S$1 billion that maintain a significant agriculture business. The six – Wilmar, Olam, Golden Agri-Resources, First Resources, Japfa and Bumitama Agri – have a combined market capitalisation of more than S$30 billion. In 3Q18, the best-performing agri stocks were Bumitama Agri (+9.2%), First Resources (+8.5%) and Wilmar (+6.4%). These three plays averaged a total return of 8.0% over the quarter, reversing their negative returns in 1H18. Japfa was the only stock that registered positive total returns of +3.1% and +25.8% for 3Q18 and 1H18 respectively.

5 Largest OSV Plays Average 21% Rebound From 12-Month Lows in 3Q18

SGX My Gateway

10 October 2018

OSV plays are widely regarded as one of the key beneficiaries of a rebound in oil prices. Crude, which has gained more than 20% since the start of the year, continues to hover near four-year highs, on fears of a sustained supply crunch. In 3Q18, the five largest SGX listed OSV stocks that saw the strongest price recovery from their 52-week lows were: Vallianz Holdings (28.6%), Mermaid Maritime (21.4%), Sinwa (21.1%), Dyna-Mac Holdings (18.0%), and PACC Offshore Services (17.4%). These five stocks averaged a 21.3% price gain from their respective 12-month troughs.

35 Companies Buy Back Shares in Sept, as STI Rebounded 1.4%

SGX My Gateway

01 October 2018

In September, 35 stocks repurchased 32 million shares for a total consideration of S$94 million. The buyback consideration has brought the total consideration over the first nine months of 2018 to SS$1.3 billion, which is three times the total buyback consideration in 2017. The 35 stocks included seven STI constituents - DBS, OCBC, CDL, SGX, Sembcorp Industries, UOB & SATS. Buybacks by these seven stocks made up as much as S$80 million, or 85%, of the S$94 million in consideration.

Key Telcos Averaged 5% Total Return in Sept18 QTD

SGX My Gateway

21 September 2018

Singtel, NetLink NBN Trust, StarHub & M1 have all generated similar gains in the September quarter-to-date, averaging +5.5% total returns, which has trimmed their average year-to-date decline in total return to -12.5%. Singtel, StarHub & M1 have averaged annualised total returns of 7.4% from respective IPO dates to present. The three companies are currently valued at similar discounts to their five year average P/E ratios. Business Trust - NetLink NBN Trust - listed in July 2017.

SGX 5 Best-Yielding Healthcare Stocks Average 5% Indicative Dividend Yield

SGX My Gateway

19 September 2018

Singapore's healthcare sector, typically viewed as a defensive segment and poised to enjoy multi-year growth prospects, has benefited from rotational fund flows recently, as investors took refuge in haven assets following a rise in risk-aversion. The five best-yielding constituents of the iEdge SG All Healthcare Index are: First REIT (6.9%), ISEC Healthcare (4.9%), Singapore O&G (4.9%), Parkway Life REIT (4.8%), and Talkmed Group (3.4%). These 5 stocks have averaged a dividend indicated yield of 5.0%.

SGX 5 Best-Performing Healthcare Plays Avg 11% Total Return in 3Q18-To-Date

SGX My Gateway

11 September 2018

Singapore's healthcare sector - typically viewed as defensive and poised to enjoy multi-year growth prospects - has benefited from rotational fund flows recently. This follows increased risk-aversion on the back of higher market volatility, rising US-China trade tensions and an emerging market currency crisis. In 3Q18 to-date, the five best-performing constituents of the SGX All Healthcare Index were: Riverstone (+14.0%), Raffles Medical Group (+11.4%), Aoxin Q & M Dental (+9.8%), Camsing Healthcare (+9.5%), and ISEC Healthcare (+8.0%). These 5 healthcare plays have averaged a total return of +10.5% over the period.

Dairy Farm International Scheduled to Join STI on 24 September 2018

SGX My Gateway

06 September 2018

Dairy Farm International is scheduled to join the STI effective Monday 24 September, replacing StarHub. On inclusion the leading pan-Asian retailer will be one of five STI constituents that are quoted and traded in USD. Dairy Farm is expected to make up between 1.0% and 1.5% of the STI weights, based on free-float information and STI weights as of 29 June 2018. The Consumer Goods Industry will then have four stocks in the STI (incl. Thai Bev, Wilmar & GAR) representing between 6% and 7% of the STI weights.

SGX Healthcare Stocks Raised USD 1 Billion in Last Five Years

SGX My Gateway

05 September 2018

SGX has one of the world's most market-oriented and efficient suite of capital-raising processes for companies. The comprehensive suite of offerings includes IPOs, rights and bonus issues, stock splits and consolidations, private placements, as well as takeovers. From 2013 to 1H 2018, healthcare stocks on SGX raised a total of US$1 billion from 16 listings (total US$211 million raised), 25 equity placements and rights issues (total US$213 million raised), and nine bond listings (total US$550 million raised)

These articles are provided by SGX My Gateway.

SGX My Gateway

SGX's investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.

These articles are not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the “SGX Group Companies”) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.

Stock / REIT Search

DBS Share Price , UOB Share Price, SingTel Share Price, OCBC Share Price
Prime US REIT IPO